豊頬術市場- 世界の産業規模、シェア、動向、機会、予測、製品別、技術別、エンドユーザー別、地域別、競合別、2020-2030F

豊頬術の世界市場は、2024年に43億8,000万米ドルと評価され、2030年には69億7,000万米ドルに達し、予測期間中のCAGRは8.02%で成長すると予測されています。

同市場は、特に若々しい顔の輪郭を取り戻そうとする高齢者の間で美容施術の需要が高まっていることから、急速に拡大しています。特に65歳以上の高齢者の間で美容治療が受け入れられつつあり、市場は豊頬術への関心の高まりから恩恵を受けています。真皮フィラーやインプラント材料の技術革新により、施術の安全性、精度、有効性が向上し、より幅広い層にとって魅力的で利用しやすいものとなっています。一部の地域では、費用に関連する課題や施術上のリスクによって利用しにくくなっているもの、製品開発の進歩や消費者の意識の高まりによって、世界の豊頬術市場は引き続き成長するとみられます。

市場促進要因

顔面美容治療に対する需要の高まり

主な市場課題

合併症と副作用のリスク

主な市場動向

自然な美へのシフト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の豊頬術市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（皮膚充填剤、インプラント、その他）
  • 技術別（外科的、非外科的）
  • エンドユーザー別（病院、クリニック、外来手術センター（ASC）、専門クリニック、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の豊頬術市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の豊頬術市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の豊頬術市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の豊頬術市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの豊頬術市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• AbbVie Inc.
• Merz Pharma GmbH & Co. KGaA
• Galderma SA
• Sientra, Inc.
• Stryker Corporation
• Sinclair
• Johnson & Johnson Services, Inc.
• Anika Therapeutics, Inc.
• Hanson Medical Inc.
• Zimmer Biomet

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Cheek Augmentation Market was valued at USD 4.38 billion in 2024 and is projected to reach USD 6.97 billion by 2030, growing at a CAGR of 8.02% during the forecast period. The market is expanding rapidly due to increasing demand for cosmetic procedures, particularly among the aging population seeking to restore youthful facial contours. With growing acceptance of aesthetic treatments, especially among individuals aged 65 and older, the market is benefitting from heightened interest in cheek augmentation. Technological innovations in dermal fillers and implant materials have improved the safety, precision, and effectiveness of procedures, making them more appealing and accessible to a wider demographic. Despite cost-related challenges and procedural risks that may limit accessibility in some regions, advancements in product development and growing consumer awareness are expected to drive continued growth in the global cheek augmentation landscape.

Key Market Drivers

Rising Demand for Facial Aesthetic Treatments

The increasing demand for facial aesthetic procedures is a significant driver of the Global Cheek Augmentation Market. In 2023, more than 34.9 million surgical and non-surgical aesthetic procedures were conducted globally, reflecting rising consumer interest in enhancing physical appearance through minimally invasive methods. Cheek augmentation procedures such as dermal fillers and implants are especially popular for achieving youthful facial contours with reduced downtime. The influence of social media platforms has further accelerated this trend by promoting beauty ideals and increasing awareness of cosmetic treatment options. As individuals increasingly prioritize appearance and self-esteem, cheek augmentation is gaining widespread acceptance across both genders and various age groups.

Key Market Challenges

Risk of Complications and Side Effects

The potential for complications and side effects remains a notable challenge in the cheek augmentation market. Surgical procedures carry risks such as infection, scarring, and asymmetry, while non-surgical methods like dermal fillers can cause swelling, bruising, or allergic reactions. Although generally safe, these risks can deter potential patients, especially where access to skilled professionals and safety standards may be limited. Additionally, dissatisfaction with aesthetic outcomes or the need for corrective procedures may further impact patient confidence. To sustain market growth, comprehensive patient education, adherence to safety protocols, and the presence of qualified practitioners are essential.

Key Market Trends

Shift Toward Natural Aesthetics

A growing preference for natural-looking enhancements is shaping demand in the cheek augmentation market. Patients are increasingly seeking subtle, balanced results that enhance facial features without appearing artificial. This shift is supported by advances in dermal filler technology, 3D imaging, and personalized treatment planning, allowing for highly tailored and precise augmentations. The trend is particularly evident in the popularity of non-surgical approaches, which provide temporary, adjustable results and align with the evolving desire for low-risk, natural aesthetic outcomes. As consumer preferences move toward refinement over transformation, procedures that emphasize harmony and proportion are expected to dominate.

Key Market Players

• AbbVie Inc.
• Merz Pharma GmbH & Co. KGaA
• Galderma SA
• Sientra, Inc.
• Stryker Corporation
• Sinclair
• Johnson & Johnson Services, Inc.
• Anika Therapeutics, Inc.
• Hanson Medical Inc.
• Zimmer Biomet

Report Scope:

In this report, the Global Cheek Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cheek Augmentation Market, By Product:

• Derma Fillers
• Implant
• Others

Cheek Augmentation Market, By Technique:

• Surgical
• Non-surgical

Cheek Augmentation Market, By End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Cheek Augmentation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cheek Augmentation Market.

Available Customizations:

Global Cheek Augmentation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Cheek Augmentation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Derma Fillers, Implant, Others)
  • 5.2.2. By Technique (Surgical, Non-surgical)
  • 5.2.3. By End User (Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Cheek Augmentation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cheek Augmentation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Cheek Augmentation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Cheek Augmentation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By End User

7. Europe Cheek Augmentation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cheek Augmentation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Cheek Augmentation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Cheek Augmentation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Cheek Augmentation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Cheek Augmentation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By End User

8. Asia-Pacific Cheek Augmentation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cheek Augmentation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By End User
  • 8.3.2. India Cheek Augmentation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Cheek Augmentation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Cheek Augmentation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Cheek Augmentation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By End User

9. South America Cheek Augmentation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cheek Augmentation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Cheek Augmentation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Cheek Augmentation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By End User

10. Middle East and Africa Cheek Augmentation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cheek Augmentation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Cheek Augmentation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Cheek Augmentation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. AbbVie Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Merz Pharma GmbH & Co. KGaA
• 14.3. Galderma SA
• 14.4. Sientra, Inc.
• 14.5. Stryker Corporation
• 14.6. Sinclair
• 14.7. Johnson & Johnson Services, Inc.
• 14.8. Anika Therapeutics, Inc.
• 14.9. Hanson Medical Inc.
• 14.10. Zimmer Biomet

15. Strategic Recommendations

16. About Us & Disclaimer